Study could alter approach to treating high blood pressure


It was 2011 when David Baldwin got a diagnosis familiar to millions of Americans: He had high blood pressure. He did as his doctor advised – lost some weight, cut back on salt and took medication. Eight months later, it had dropped a little.

“That’s when I saw the flier on the elevator at work,” said Baldwin, a research coordinator at the University of Alabama at Birmingham who was 62 at the time.

That was his ticket into a study that, four years later, is now likely to launch a wave of newly aggressive treatment of high blood pressure across the U.S. Results showed 43 percent fewer cardiovascular disease-related deaths in patients who dropped their systolic pressure to near 120 – instead of settling for under 140, the target that has long been considered acceptable – in findings that headlined the American Heart Association’s annual Scientific Sessions in Orlando, Florida.

According to the AHA, one out of every three American adults – about 80 million – has high blood pressure, increasing their risk for heart disease, stroke and other health problems. For more on this story, CLICK HERE. 

Share This Story

Be the first to comment

Please check your e-mail for a link to activate your account.